T. Sohda, Y. Momose, K. Meguro, Y. Kawamatsu, Y. Sugiyama et al., Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[ 4-(pyridylalkoxy)benzyl -2, p.4

J. Reddy, S. Goel, M. Nemali, J. Carrino, T. Laffler et al., Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators., Proceedings of the National Academy of Sciences, vol.83, issue.6, pp.1747-1751, 1986.
DOI : 10.1073/pnas.83.6.1747

B. Staels, A. Van-tol, G. Verhoeven, and J. Auwerx, Apolipoprotein A-IV Messenger Ribonucleic Acid Abundance Is Regulated in a Tissue-Specific Manner*, Endocrinology, vol.126, issue.4, pp.2153-2163, 1990.
DOI : 10.1210/endo-126-4-2153

I. Issemann and S. Green, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, vol.347, issue.6294, pp.645-650, 1990.
DOI : 10.1038/347645a0

S. Kliewer, K. Umesono, D. Noonan, R. Heyman, and R. Evans, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature, vol.358, issue.6389, pp.771-774, 1992.
DOI : 10.1038/358771a0

J. Tugwood, I. Issemann, R. Anderson, K. Bundell, W. Mcpheat et al., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5 flanking sequence of the rat acyl CoA oxidase gene ?, Embo J, vol.11, pp.433-439, 1992.

C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein et al., Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors

S. Lee, T. Pineau, J. Drago, E. Lee, J. Owens et al., Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators., Molecular and Cellular Biology, vol.15, issue.6, pp.3012-3022, 1995.
DOI : 10.1128/MCB.15.6.3012

C. Cheung, T. Akiyama, J. Ward, C. Nicol, L. Feigenbaum et al., Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-Activated Receptor ??, Cancer Research, vol.64, issue.11, pp.3849-3854, 2004.
DOI : 10.1158/0008-5472.CAN-04-0322

B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf et al., Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism, Circulation, vol.98, issue.19, pp.2088-2093, 1998.
DOI : 10.1161/01.CIR.98.19.2088

N. Marx, H. Duez, J. Fruchart, and B. Staels, Peroxisome Proliferator-Activated Receptors and Atherogenesis: Regulators of Gene Expression in Vascular Cells, Circulation Research, vol.94, issue.9, pp.1168-1178, 2004.
DOI : 10.1161/01.RES.0000127122.22685.0A

P. Tontonoz, E. Hu, and B. Spiegelman, Stimulation of adipogenesis in fibroblasts by PPAR??2, a lipid-activated transcription factor, Cell, vol.79, issue.7, pp.1147-1156, 1994.
DOI : 10.1016/0092-8674(94)90006-X

P. Tontonoz, E. Hu, R. Graves, A. Budavari, and B. Spiegelman, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer., Genes & Development, vol.8, issue.10, pp.1224-1234, 1994.
DOI : 10.1101/gad.8.10.1224

J. Lehmann, L. Moore, T. Smith-oliver, W. Wilkison, T. Willson et al., An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor ?? (PPAR??), Journal of Biological Chemistry, vol.270, issue.22, pp.12953-12956, 1995.
DOI : 10.1074/jbc.270.22.12953

S. Kahn, S. Haffner, M. Heise, W. Herman, R. Holman et al., Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy, New England Journal of Medicine, vol.355, issue.23, pp.2427-2443, 2006.
DOI : 10.1056/NEJMoa066224

J. Dormandy, B. Charbonnel, D. Eckland, E. Erdmann, M. Massi-benedetti et al., Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone 46 Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity, Bioorg Med Chem Lett, vol.13, pp.1517-1521, 2003.

J. Berger, M. Leibowitz, T. Doebber, A. Elbrecht, B. Zhang et al., Novel Peroxisome Proliferator-activated Receptor (PPAR) ?? and PPAR?? Ligands Produce Distinct Biological Effects, Journal of Biological Chemistry, vol.274, issue.10, pp.6718-6725, 1999.
DOI : 10.1074/jbc.274.10.6718

C. Lee, P. Olson, A. Hevener, I. Mehl, L. Chong et al., PPAR?? regulates glucose metabolism and insulin sensitivity, Proceedings of the National Academy of Sciences, vol.103, issue.9, pp.3444-3449, 2006.
DOI : 10.1073/pnas.0511253103

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413918

X. Qin, X. Xie, Y. Fan, J. Tian, Y. Guan et al., Peroxisome proliferator-activated receptor-?? induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice, Hepatology, vol.536, issue.2, pp.432-441, 2008.
DOI : 10.1002/hep.22334

W. Oliver, . Jr, J. Shenk, M. Snaith, C. Russell et al., A selective peroxisome proliferator-activated receptor ?? agonist promotes reverse cholesterol transport, Proceedings of the National Academy of Sciences, vol.98, issue.9, pp.5306-5311, 2001.
DOI : 10.1073/pnas.091021198

S. Luquet, J. Lopez-soriano, D. Holst, A. Fredenrich, J. Melki et al., Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability, Faseb J, vol.17, pp.2299-2301, 2003.

Y. Wang, C. Zhang, R. Yu, H. Cho, M. Nelson et al., Regulation of Muscle Fiber Type and Running Endurance by PPAR??, PLoS Biology, vol.98, issue.10, p.294, 2004.
DOI : 10.1371/journal.pbio.0020294.sv002

C. Fievet, J. Fruchart, and B. Staels, PPAR?? and PPAR?? dual agonists for the treatment of type 2 diabetes and the metabolic syndrome, Current Opinion in Pharmacology, vol.6, issue.6, pp.606-614, 2006.
DOI : 10.1016/j.coph.2006.06.009

R. Henry, A. Lincoff, S. Mudaliar, M. Rabbia, C. Chognot et al., Effect of the dual peroxisome proliferator-activated receptor-??/?? agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study, The Lancet, vol.374, issue.9684, pp.126-135, 2009.
DOI : 10.1016/S0140-6736(09)60870-9

J. Wallace, M. Schwarz, P. Coward, J. Houze, J. Sawyer et al., Effects of peroxisome proliferator-activated receptor ??/?? agonists on HDL-cholesterol in vervet monkeys, The Journal of Lipid Research, vol.46, issue.5, pp.1009-1016, 2005.
DOI : 10.1194/jlr.M500002-JLR200